Zdrowie i gospodarka · 14/08/2014

FDA Clears DRIXORAL Tablets for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has officially determined that DRIXORAL tablets, along with other listed drug products, were not withdrawn from the market due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for these products as long as they meet regulatory requirements.